SCHEMBL18554580

SCHEMBL18554580

COc1cc[c]c(C(N)=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.50
PARP10 Q53GL7 2/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
PARP4 Q9UKK3 1/20 0.47
KDM4E B2RXH2 3/20 0.41
MAPK1 P28482 2/20 0.41
PRNP P04156 1/20 0.41
TSHR P16473 1/20 0.41
PPARG P37231 1/20 0.41
HTT P42858 1/20 0.41
MAPK10 P53779 1/20 0.41
NCOA2 Q15596 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
HPGDS O60760 1/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CES2 O00748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905353 0.86 NPC1 (0.44) PARP1CA1CA2KDM4EMAPK1
SCHEMBL8321846 0.85 ALDH1A1 (0.46) PARP1CA1CA2KDM4EMAPK1
SCHEMBL4626860 0.85 KDM4E (0.46) CA1CA2KDM4EPOLBSMN1; SMN2
SCHEMBL1637879 0.83 CA1 (0.46) CA1CA2KDM4EMAPK1HTT
SCHEMBL10397908 0.80 HSD17B2 (0.39) PARP1KDM4ETSHRSMN1; SMN2CES2
SCHEMBL7575058 0.80 PLK1 (0.49) KDM4ETSHRHTTRXFP1HPGDS
SCHEMBL27470832 0.78 HPGD (0.47) CA1CA2KDM4EMAPK1TSHR
SCHEMBL7467641 0.77 PIM1 (0.41) KDM4E
SCHEMBL27575507 0.76 ESR1 (0.43) PARP1HTTSMN1; SMN2CES2CES1
SCHEMBL2895076 0.75 PARP1 (0.41) PARP1PARP10CA1CA2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017034872-A1 INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 WO disclosed
CN-101405268-A Amide derivatives and their use for the treatment of protein-related diseases NOVARTIS AG (CH) 2009-04-08 CN disclosed
CN-1171788-A Therapeutic agent for osteoporosis and triaza * compound JAPAN TOBACCO INC (JP) 1998-01-28 CN disclosed